Philadelphia, PA, United States of America

Stephanie F Guerrera

This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephanie F Guerrera. Retrieved from https://idiyas.com/inventor/stephanie-f-guerrera

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephanie F Guerrera

Introduction

Stephanie F Guerrera, an accomplished inventor based in Philadelphia, PA, has made significant contributions to the field of biotechnology. With one patent to her name, she has demonstrated her commitment to advancing therapeutic methods through scientific innovation. Her work continues to inspire others in the realm of medical research and development.

Latest Patents

Stephanie's most notable patent is centered on the cytokine family member EF-7. The patent covers EF-7 polypeptides and polynucleotides, alongside methods for producing such polypeptides using recombinant techniques. Additionally, she has disclosed various methods for utilizing EF-7 polypeptides and polynucleotides in therapy, as well as in diagnostic assays. This innovation has the potential to significantly enhance therapeutic approaches and diagnostic techniques in medicine.

Career Highlights

Currently, Stephanie F Guerrera works with the renowned SmithKline Beecham Corporation, where she applies her expertise in biotechnology. Her contributions focus on developing new therapeutic strategies and innovative products that address unmet medical needs. Stephanie's work exemplifies the intersection of research and practical application, showcasing how scientific discovery can lead to impactful health solutions.

Collaborations

Throughout her career, Stephanie has collaborated with esteemed colleagues, including Sherin Salaheldin Abdel-Meguid and Rajeev Aurora. These collaborations have fostered an environment of shared knowledge and collective innovation, contributing to the successful development of her patented technologies.

Conclusion

In summary, Stephanie F Guerrera is a pioneering inventor whose work in the biotechnological domain continues to influence the medical landscape. With her patent on EF-7 polypeptides and polynucleotides, she is paving the way for future innovations in therapy and diagnostics. Her collaborations and dedication further highlight the importance of teamwork in advancing scientific knowledge and application.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…